Allstate Corporation’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Allstate Corporation’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,107	Closed	-$382K	–	808
2021 Q4	$382K	Sell	4,107 -196	-5%	-$12.9K	0.01%	705
2021 Q3	$256K	Sell	4,303 -19	-0.4%	-$1.12K	0.01%	658
2021 Q2	$295K	Sell	4,322 -92	-2%	-$6K	0.01%	654
2021 Q1	$306K	Hold	4,414	–	–	0.01%	659
2020 Q4	$339K	Buy	4,414 +739	+20%	+$55.4K	0.01%	594
2020 Q3	$275K	Sell	3,675 -456	-11%	-$30.4K	0.01%	588
2020 Q2	$260K	Buy	+4,131	New	+$227K	0.01%	613

Allstate Corporation's ARNA Position: Q1 2022 in Review

Allstate Corporation sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 4,107 shares — an estimated $382K sold.

Allstate Corporation first reported a position in ARNA in Q2 2020 and held it in 7 quarters. The position peaked at $382K in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Allstate Corporation reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Allstate Corporation sold 4,107 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $382K.
Allstate Corporation first reported a position in Arena Pharmaceuticals Inc in Q2 2020 and held it in 7 quarters.
Allstate Corporation's Arena Pharmaceuticals Inc position peaked at $382K in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Allstate Corporation's 13F filing for Q1 2022, filed 16 May 2022.